In this section, we report observed 5-year survival by main diagnostic cancer groups according to the third version of the International Classification of Childhood Cancer (ICCC31), and for Langerhans cell histiocytosis and for all cancers combined. We report 5-year survival for the calendar period 2013-2022, for children (0-14 years old) and adolescents (15-19 years old), separately and combined (0-19 years old). We also publish observed survival by 10-year periods of cancer diagnosis starting in 1983. Sex-specific 1-, 5- and 10-year observed survival is reported by calendar period (1998-2007, 2008-2017, 2018-2022) for children (0-14 years old) and adolescents (15-19 years old), separately and combined (0-19 years old).
Survival is estimated as the percentage of patients still alive at a given time t (in years) after diagnosis. We follow the same methodology as that used for the Swiss Cancer Report 2021 – Methods Report (available only in German). A more technical description of the methods is provided in chapter 3 of the Statistical methods for Cancer Reporting in Switzerland.
The tables and figures of this section can be cited as follows: Title of figure or table (2025). Figures: Survival. Childhood Cancer Registry. URL https://www.childhoodcancerregistry.ch. Accessed: date.
1 Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 2005 Apr 1;103(7):1457-67. doi: 10.1002/cncr.20910. PMID: 15712273.